812 related articles for article (PubMed ID: 30978358)
1. Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
Auricchio R; Mandile R; Del Vecchio MR; Scapaticci S; Galatola M; Maglio M; Discepolo V; Miele E; Cielo D; Troncone R; Greco L
Gastroenterology; 2019 Aug; 157(2):413-420.e3. PubMed ID: 30978358
[TBL] [Abstract][Full Text] [Related]
2. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
[TBL] [Abstract][Full Text] [Related]
4. Patchy villous atrophy of the duodenum in childhood celiac disease.
Bonamico M; Mariani P; Thanasi E; Ferri M; Nenna R; Tiberti C; Mora B; Mazzilli MC; Magliocca FM
J Pediatr Gastroenterol Nutr; 2004 Feb; 38(2):204-7. PubMed ID: 14734885
[TBL] [Abstract][Full Text] [Related]
5. Potential celiac children: 9-year follow-up on a gluten-containing diet.
Auricchio R; Tosco A; Piccolo E; Galatola M; Izzo V; Maglio M; Paparo F; Troncone R; Greco L
Am J Gastroenterol; 2014 Jun; 109(6):913-21. PubMed ID: 24777149
[TBL] [Abstract][Full Text] [Related]
6. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
[TBL] [Abstract][Full Text] [Related]
7. Natural history of potential celiac disease in children.
Tosco A; Salvati VM; Auricchio R; Maglio M; Borrelli M; Coruzzo A; Paparo F; Boffardi M; Esposito A; D'Adamo G; Malamisura B; Greco L; Troncone R
Clin Gastroenterol Hepatol; 2011 Apr; 9(4):320-5; quiz e36. PubMed ID: 20851213
[TBL] [Abstract][Full Text] [Related]
8. Features and Progression of Potential Celiac Disease in Adults.
Volta U; Caio G; Giancola F; Rhoden KJ; Ruggeri E; Boschetti E; Stanghellini V; De Giorgio R
Clin Gastroenterol Hepatol; 2016 May; 14(5):686-93.e1. PubMed ID: 26538207
[TBL] [Abstract][Full Text] [Related]
9. Specific celiac disease antibodies in children on a gluten-free diet.
Hogen Esch CE; Wolters VM; Gerritsen SA; Putter H; von Blomberg BM; van Hoogstraten IM; Houwen RH; van der Lely N; Mearin ML
Pediatrics; 2011 Sep; 128(3):547-52. PubMed ID: 21859913
[TBL] [Abstract][Full Text] [Related]
10. Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease.
Caruso R; Marafini I; Del Vecchio Blanco G; Fina D; Paoluzi OA; Colantoni A; Sedda S; Pallone F; Monteleone G
Dig Liver Dis; 2014 Apr; 46(4):323-9. PubMed ID: 24394601
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
[TBL] [Abstract][Full Text] [Related]
12. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
[TBL] [Abstract][Full Text] [Related]
13. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
Husby S; Murray JA; Katzka DA
Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
[TBL] [Abstract][Full Text] [Related]
14. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease.
Zanini B; Magni A; Caselani F; Lanzarotto F; Carabellese N; Villanacci V; Ricci C; Lanzini A
Dig Liver Dis; 2012 Apr; 44(4):280-5. PubMed ID: 22119616
[TBL] [Abstract][Full Text] [Related]
15. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
Murray JA; Kelly CP; Green PHR; Marcantonio A; Wu TT; Mäki M; Adelman DC;
Gastroenterology; 2017 Mar; 152(4):787-798.e2. PubMed ID: 27864127
[TBL] [Abstract][Full Text] [Related]
16. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.
Montenegro L; Piscitelli D; Giorgio F; Covelli C; Fiore MG; Losurdo G; Iannone A; Ierardi E; Di Leo A; Principi M
World J Gastroenterol; 2014 Dec; 20(46):17686-9. PubMed ID: 25516687
[TBL] [Abstract][Full Text] [Related]
17. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease.
Singh P; Kurray L; Agnihotri A; Das P; Verma AK; Sreenivas V; Dattagupta S; Makharia GK
J Clin Gastroenterol; 2015 Mar; 49(3):212-7. PubMed ID: 24583754
[TBL] [Abstract][Full Text] [Related]
18. Genetic and flow cytometry analysis of seronegative celiac disease: a cohort study.
Ríos León R; Crespo Pérez L; Rodríguez de Santiago E; Roy Ariño G; De Andrés Martín A; García Hoz Jiménez C; Sánchez Rodríguez E; Saiz González A; León Prieto F; Albillos A
Scand J Gastroenterol; 2019 May; 54(5):563-570. PubMed ID: 31057009
[No Abstract] [Full Text] [Related]
19. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.
Kaukinen K; Sulkanen S; Mäki M; Collin P
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698
[TBL] [Abstract][Full Text] [Related]
20. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.
Borrelli M; Maglio M; Korponay-Szabó IR; Vass V; Mearin ML; Meijer C; Niv-Drori H; Ribes-Koninckx C; Roca M; Shamir R; Troncone R; Auricchio R
Clin Exp Immunol; 2018 Mar; 191(3):311-317. PubMed ID: 29114847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
